Raleigh's BioDelivery Sciences reaches finish line on drug development
June 06, 2014 at 18:05 PM EDT
Raleigh drug developer BioDelivery Sciences International received some of the best news in company history Friday when the FDA approved its new drug application for Bunavail, a treatment for opioid dependence...